Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06460948 · ClinicalTrials.gov registry record · Early Phase 1
Identifying Oxytocin Deficiency in Adults With Pituitary Disease
A Early Phase 1 study of Arginine Vasopressin Deficiency and Oxytocin Deficiency, sponsored by Elizabeth Austen Lawson.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 32
- Enrollment target
- 1
- Study location
NCT06460948 is a Early Phase 1 study of Arginine Vasopressin Deficiency and Oxytocin Deficiency that is actively recruiting participants, run by Elizabeth Austen Lawson. The registered enrollment target is 32 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06460948, a Early Phase 1 study of Arginine Vasopressin Deficiency and Oxytocin Deficiency, is actively recruiting participants, sponsored by Elizabeth Austen Lawson.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 32 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an open-label, pilot study, to characterize oxytocin response to a single dose of oral Estrogen-progestin in patients with arginine-vasopressin deficiency compared to healthy controls. The association between oxytocin levels and measures of psychopathology (i.e., anxiety and depression) and quality of life across groups will be examined. We hypothesize that: 1. Salivary and blood oxytocin response to Estrogen-progestin will be lower in arginine-vasopressin deficiency compared to healthy control. 2. Lower salivary and blood oxytocin levels will be associated with more severe symptoms of anxiety, depression, and social emotional difficulties as well as lower quality of life.
Conditions Studied
Interventions
- DRUG Norethindrone Acetate-Ethinyl Estradiol
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2024-11-13 |
| Est. Completion | 2026-06 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06460948
The ClinicalTrials.gov registry entry for NCT06460948 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Elizabeth Austen Lawson, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Arginine Vasopressin Deficiency appearing as the primary indexed condition, and to 1 intervention - of which Norethindrone Acetate-Ethinyl Estradiol is the first listed.
NCT06460948 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06460948 about?
NCT06460948 is a clinical study titled "Identifying Oxytocin Deficiency in Adults With Pituitary Disease". This is an open-label, pilot study, to characterize oxytocin response to a single dose of oral Estrogen-progestin in patients with arginine-vasopressin deficiency compared to healthy controls. The association between oxytocin levels and measures of psychopathology (i.e., anxiety and depression) and ...
What is the current status of trial NCT06460948?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 32 participants. The study started on 2024-11-13. Estimated completion is 2026-06.
What conditions does trial NCT06460948 study?
This clinical trial studies the following conditions: Arginine Vasopressin Deficiency, Oxytocin Deficiency.
What interventions are being tested in trial NCT06460948?
The interventions under investigation include: Norethindrone Acetate-Ethinyl Estradiol (DRUG).
Who is sponsoring clinical trial NCT06460948?
This trial is sponsored by Elizabeth Austen Lawson, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06460948 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Arginine Vasopressin Deficiency
All registered trials for this condition
Oxytocin Deficiency
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.